Skip to main content
JLK, Inc. logo

JLK, Inc. — Investor Relations & Filings

Ticker · 322510 ISIN · KR7322510009 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 303 across all filing types
Latest filing 2020-05-11 Regulatory Filings
Country KR South Korea
Listing KO 322510

About JLK, Inc.

https://www.jlkgroup.com/en/

JLK, Inc. is an artificial intelligence company that develops medical and data solutions. The company specializes in AI-driven technologies for the entire stroke treatment cycle, from diagnosis to prognosis. Its flagship platform, MEDIHUB STROKE, is a comprehensive solution that utilizes multi-modality medical imaging analysis (CT, MRI) to provide rapid and precise decision support for both ischemic and hemorrhagic strokes. Beyond its primary focus on stroke care, JLK's MEDIHUB platform also includes solutions for dementia and cancer. The company has also developed MEDIHUB TELE, an AI-powered telemedicine platform for remote consultations, and Hello Data, a data management platform optimized for AI machine learning that serves the medical sector and other industries, including autonomous driving and manufacturing.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(HelloHealth Gateway(1등급 유헬스케어게이트웨이) 국내 인허가 신청 완료)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (JLK) regarding a 'major management matter' (투자판단 관련 주요경영사항), specifically the submission of a medical device license application to the Ministry of Food and Drug Safety. Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a standard regulatory disclosure of a business event, it is classified as a Regulatory Filing (RNS).
2020-05-11 Korean
투자판단관련주요경영사항(인공지능 기반 의료 솔루션 호주 의료기기 품목허가 신청 (총 7건))
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (JLK) regarding a material business event: the submission of medical device approval applications to the Australian Therapeutic Goods Administration (TGA). It follows the standard format for 'Major Management Matters' (주요경영사항) filings in the Korean market. Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a formal regulatory disclosure of a business development, it is classified as a Regulatory Filing (RNS).
2020-05-11 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) by JLK. It details the contract value, counterparty, and terms. Since this is a specific corporate announcement regarding a business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2020-05-11 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by JLK. It details the contract value, the counterparty, the nature of the goods (AI lung disease analysis solution), and the contract duration. Since this is a specific regulatory disclosure of a material contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2020-05-06 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a shareholder meeting (주주총회소집결의) for the company JLK. It details the date, location, and agenda items (specifically the appointment of an auditor). This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2020-04-29 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Extraordinary General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal notice of a corporate action. Given it is a regulatory announcement that does not fit into specific categories like dividend or share buyback, it falls under the general regulatory filing category.
2020-04-29 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.